Forms Processing
PRODUCTS
-
Pharmaceutical labeling and kitting are critical for ensuring drug safety, compliance, and efficiency. Explore advanced technology and regulatory adherence to streamline these processes.
-
Compliance solutions for product development agility and audit readiness.
-
TrialScope Disclose is the industry’s most trusted and comprehensive clinical trial disclosure solution. Simplify, centralize, and gain complete control of your entire global disclosure process from trial planning to results submission, ensuring full transparency and regulatory disclosure compliance at every stage.
-
RImanager centralizes regulatory and product data, integrates with production, and streamlines planning, tracking, and approvals to bring new drugs to market faster and reliably.
-
At ProPharma, our Cell and Gene Therapy consulting team offers a comprehensive and integrated approach to early-stage cell and gene therapy development. Our expert team provides a range of services, including IND/CTA preparation, manufacturing technology, safety and risk assessment, and development planning, to help our clients navigate the complex and ever-changing landscape of cell and gene therapy development.
WHITE PAPERS AND CASE STUDIES
-
Enhancing Data Capabilities For Greenville Water Utility
The Greenville Water Utility in Indiana is leveraging Qatium to enhance its water management and leak detection capabilities, significantly improving service efficiency.
-
Transforming Development Through Mass Spectrometry Data Analysis
Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.
-
Patented Process For Intermediates Useful For Deucravacitinib
Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Leading Recruitment With A Strong Alzheimer's Referral Pool
A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
-
Navigating The European Market's Regulatory Complexities
Prepare your EU launch strategy with this comprehensive guide detailing what is needed to ensure compliance and efficiency in the EU market.
-
How To Manage Burgeoning Data Traffic On A Finite RF Spectrum
Explore strategies and innovations to unlock higher-frequency bandwidths, which are crucial for sustaining technological advancement and meeting the escalating demands of our connected future.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
Transforming PSP Enrollment To Enhance User Experiences And Optimize Workflows
Lengthy enrollment calls burden patients and PSP teams alike. See how a digital-first intake approach cut onboarding time and improved outcomes for everyone involved.
-
Sustainable Solutions For Medical Devices
Explore how medical device companies aim to balance patient safety with environmental stability by offering bio-based UHMWPE, which reduces carbon footprints by up to 70%.
-
Development And Regulation Of Veterinary Monoclonals
Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future.
-
Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies
In an example using rituximab and its biosimilars, explore the significance of minor differences of glycosylation in antibodies and its impact on their properties and functionality.
NEWS
-
Bioxytran Develops A Groundbreaking Treatment To Combat Bird Flu In Egg Laying Chickens Potentially Saving Billions3/12/2025
BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against Highly Pathogenic Avian Influenza (HPAI), commonly known as Bird Flu.
-
Five Digital Solutions Shaping The Path Toward Global Water Digitalization3/25/2026
These five solutions are generative AI, agent-based architectures, cybersecurity, early warning systems, and public-private partnerships to boost operational efficiency, according to the latest Xylem Vue report, which identifies the key strategies shaping water management in 2026.
-
Lyzr Launches Enterprise-Grade AI Agents For Procurement Across Sourcing And Vendor Management1/22/2026
Lyzr announced the launch of its AI-powered Procurement Agents, a new category of autonomous agents designed to modernize sourcing, procurement, and vendor management across large enterprises.
-
Artificio Processes Documents In 80+ Languages, Enabling Multinational Corporations To Automate Global Operations12/9/2025
Artificio Products Inc., a leader in AI-powered intelligent document processing and enterprise workflow automation, today announced that its platform now processes documents in more than 80 languages, positioning the company as a comprehensive solution for multinational corporations managing cross-border document operations.
-
Freehand Debuts As New Company With Dedicated AI Teams For Supply Chain Spend Management2/9/2026
Freehand, a newly formed agentic AI studio for supply chain and finance teams, today announced its official launch at Manifest 2026, with a mission to deploy autonomous AI Teams that take over the operational work humans have been doing by hand across procure-to-pay.